Outcome of Candida auris contact investigations conducted in a 6 month period at a New York City hospital
Copyright © 2023 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved..
Candida auris is a multidrug-resistant fungus that has led to health care-associated outbreaks globally. Contact investigations for new cases of Candida auris are a recommended infection prevention practice; however, there is limited knowledge and experience with such investigations. We describe our institution's experience from June 2018 through January 2019.
| Medienart: |
E-Artikel |
|---|
| Erscheinungsjahr: |
2024 |
|---|---|
| Erschienen: |
2024 |
| Enthalten in: |
Zur Gesamtaufnahme - volume:52 |
|---|---|
| Enthalten in: |
American journal of infection control - 52(2024), 4 vom: 22. März, Seite 491-492 |
| Sprache: |
Englisch |
|---|
| Beteiligte Personen: |
Walits, Emily [VerfasserIn] |
|---|
| Links: |
|---|
| Themen: |
Antifungal Agents |
|---|
| Anmerkungen: |
Date Completed 22.03.2024 Date Revised 22.03.2024 published: Print-Electronic Citation Status MEDLINE |
|---|
| doi: |
10.1016/j.ajic.2023.10.005 |
|---|
| funding: |
|
|---|---|
| Förderinstitution / Projekttitel: |
|
| PPN (Katalog-ID): |
NLM363312056 |
|---|
| LEADER | 01000caa a22002652 4500 | ||
|---|---|---|---|
| 001 | NLM363312056 | ||
| 003 | DE-627 | ||
| 005 | 20240323000225.0 | ||
| 007 | cr uuu---uuuuu | ||
| 008 | 231226s2024 xx |||||o 00| ||eng c | ||
| 024 | 7 | |a 10.1016/j.ajic.2023.10.005 |2 doi | |
| 028 | 5 | 2 | |a pubmed24n1341.xml |
| 035 | |a (DE-627)NLM363312056 | ||
| 035 | |a (NLM)37838250 | ||
| 035 | |a (PII)S0196-6553(23)00681-8 | ||
| 040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
| 041 | |a eng | ||
| 100 | 1 | |a Walits, Emily |e verfasserin |4 aut | |
| 245 | 1 | 0 | |a Outcome of Candida auris contact investigations conducted in a 6 month period at a New York City hospital |
| 264 | 1 | |c 2024 | |
| 336 | |a Text |b txt |2 rdacontent | ||
| 337 | |a ƒaComputermedien |b c |2 rdamedia | ||
| 338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
| 500 | |a Date Completed 22.03.2024 | ||
| 500 | |a Date Revised 22.03.2024 | ||
| 500 | |a published: Print-Electronic | ||
| 500 | |a Citation Status MEDLINE | ||
| 520 | |a Copyright © 2023 Association for Professionals in Infection Control and Epidemiology, Inc. Published by Elsevier Inc. All rights reserved. | ||
| 520 | |a Candida auris is a multidrug-resistant fungus that has led to health care-associated outbreaks globally. Contact investigations for new cases of Candida auris are a recommended infection prevention practice; however, there is limited knowledge and experience with such investigations. We describe our institution's experience from June 2018 through January 2019 | ||
| 650 | 4 | |a Journal Article | |
| 650 | 4 | |a Emerging fungal infections | |
| 650 | 4 | |a Health care–associated outbreaks | |
| 650 | 4 | |a Infection control | |
| 650 | 4 | |a Multidrug resistant fungus | |
| 650 | 7 | |a Antifungal Agents |2 NLM | |
| 700 | 1 | |a Schaefer, Sarah |e verfasserin |4 aut | |
| 773 | 0 | 8 | |i Enthalten in |t American journal of infection control |d 1980 |g 52(2024), 4 vom: 22. März, Seite 491-492 |w (DE-627)NLM012639850 |x 1527-3296 |7 nnns |
| 773 | 1 | 8 | |g volume:52 |g year:2024 |g number:4 |g day:22 |g month:03 |g pages:491-492 |
| 856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.ajic.2023.10.005 |3 Volltext |
| 912 | |a GBV_USEFLAG_A | ||
| 912 | |a GBV_NLM | ||
| 951 | |a AR | ||
| 952 | |d 52 |j 2024 |e 4 |b 22 |c 03 |h 491-492 | ||